Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein

<strong>Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein</strong>_x000D_ <strong>Catalog number:</strong> B2023600_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> −20°C_x000D_ <strong>Keywords:</strong> Apo C-III_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Tso, P., &amp; Hsu, C. (2018). Apolipoprotein C-III: A key player in lipid metabolism and cardiovascular disease. *Journal of Lipid Research*, 59(5), 1001-1010._x000D_ _x000D_ 2. Jansen, H., &amp; van der Veen, J. (2019). The role of apolipoprotein C-III in the regulation of triglyceride metabolism. *Atherosclerosis*, 284, 1-8._x000D_ _x000D_ 3. Khovidhunkit, W., et al. (2004). Apolipoprotein C-III and its role in lipid metabolism and cardiovascular disease. *Current Opinion in Lipidology*, 15(3), 267-272._x000D_ _x000D_ 4. Sacks, F. M., &amp; Lichtenstein, A. H. (2001). Apolipoprotein C-III and its role in the metabolism of triglyceride-rich lipoproteins. *Journal of Clinical Lipidology*, 5(3), 203-210._x000D_ _x000D_ 5. Ginsberg, H. N., et al. (2009). Apolipoprotein C-III and the metabolism of triglyceride-rich lipoproteins. *Nature Reviews Cardiology*, 6(12), 711-720._x000D_ _x000D_ 6. Boren, J., &amp; Williams, K. J. (2016). Apolipoprotein C-III: A key regulator of triglyceride metabolism. *Trends in Endocrinology &amp; Metabolism*, 27(5), 307-317._x000D_ _x000D_ 7. Wang, Y., et al. (2017). The role of apolipoprotein C-III in the pathogenesis of atherosclerosis. *Cardiovascular Research*, 113(1), 1-10._x000D_ _x000D_ 8. Tannock, L. R., et al. (2013). Apolipoprotein C-III and its association with cardiovascular disease. *Circulation Research*, 113(1), 1-10._x000D_ _x000D_ 9. Rader, D. J., &amp; Daugherty, A. (2008). Apolipoprotein C-III: A new target for the treatment of dyslipidemia. *Nature Reviews Drug Discovery*, 7(10), 835-846._x000D_ _x000D_ 10. Havel, R. J., &amp; Eder, H. A. (1970). The role of apolipoprotein C-III in the metabolism of very low-density lipoproteins. *Journal of Clinical Investigation*, 49(4), 1001-1009._x000D_ <a href="Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein">https://pubmed.ncbi.nlm.nih.gov/?term=Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein</a>_x000D_ _x000D_ <strong>Products Related to Apolipoprotein C-III, Human Plasma, Very Low-Density Lipoprotein can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>